Home Medication antiviral
Home Medication antiviral

valganciclovir

J - Antiinfectives For Systemic Use -> J05 - Antivirals For Systemic Use -> J05A - Direct Acting Antivirals -> J05AB - Nucleosides And Nucleotides Excl. Reverse Transcriptase Inhibitors -> J05AB14 - Valganciclovir
Administration category: Free Medicine group: antiviral Brand name: Valcyte

Safety margins

≥ 18 years
Weight ROA Dosage
ROA:
 po 		Dosage:
 min. 900mg 1 dd to max. 900mg 2 dd

Kidney function

≥ 18 years
ROA GFR Dosage Interval Comments
ROA: po
GFR:
 <10 		Dosage:
 do not prescribe

Notes GFR general:

Volwassenen:

Inductiebehandeling: 1e gift altijd normale dosis, vervolgens:
kreatinineklaring 40–59 ml/min: 450 mg 2×/dag;
25–39 ml/min: 450 mg 1 ×/dag;
10–24 ml/min: 450 mg om de dag.

Onderhoudsbehandeling, of profylaxe:
kreatinineklaring 40–59 ml/min: 450 mg 1 ×/dag;
25–39 ml/min: 450 mg om de dag;
10–24 ml/min: 450 mg 2 ×/week.

Toediening bij een kreatinineklaring < 10 ml/min wordt niet aanbevolen.

Renal elimination: 90%
Dosage: dependent on kidney function

Renal function-replacement therapy

CAPD: gebruik vermijden

Hemo dialysis: inductiebehandeling: 200 mg na elke dialyse, eerste gift normale dosis. Onderhoudsbehandeling: 100 mg na elke dialyse.

CAV / VVHD: gebruik vermijden

Pregnancy

Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:

For individual advice, consult an expert on site.
Metadata

Swab vid: M-2064.4
Updated: 03/26/2024 - 17:16
Status: Published

External links
Menu position